Mereo BioPharma Group Ownership | Who Owns Mereo BioPharma Group?

Mereo BioPharma Group Ownership Summary

Mereo BioPharma Group is owned by 14.13% institutional investors, 1.03% insiders, and 84.85% retail investors. Janus henderson group is the largest institutional shareholder, holding 2.22% of MREO shares. UBS (Lux) EF Biotech (USD) P-acc is the top mutual fund, with 0.55% of its assets in Mereo BioPharma Group shares.

MREO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Mereo BioPharma Group	14.13%	1.03%	84.85%
Sector	Healthcare Stocks	57.47%	9.40%	33.13%
Industry	Biotech Stocks	69.06%	8.93%	22.01%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Janus henderson group	17.12M	2.22%	$59.84M
Rubric capital management lp	15.31M	1.99%	$53.58M
Rock springs capital management lp	9.60M	1.25%	$33.60M
Adage capital partners gp	8.72M	1.13%	$30.50M
Mangrove partners	8.64M	1.12%	$30.23M
Deerfield management company, l.p. (series c)	6.71M	0.87%	$23.49M
Frazier life sciences management	4.40M	0.63%	$15.84M
Alkeon capital management	4.70M	0.61%	$16.44M
683 capital management	4.55M	0.59%	$15.93M
Millennium management	3.97M	0.51%	$13.88M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Tejara capital	2.32M	5.31%	$8.11M
Mangrove partners	8.64M	3.34%	$30.23M
Acuta capital partners	779.31K	2.74%	$2.73B
Great point partners	1.15M	1.90%	$4.03M
Clearline capital lp	3.22M	1.49%	$11.26M
Rock springs capital management lp	9.60M	1.28%	$33.60M
683 capital management	4.55M	0.99%	$15.93M
Frazier life sciences management	4.40M	0.74%	$15.84M
Rubric capital management lp	15.31M	0.69%	$53.58M
Healthinvest partners ab	390.00K	0.65%	$1.37M

Top Buyers

Holder	Shares	% Assets	Change
Janus henderson group	17.12M	0.03%	4.78M
Frazier life sciences management	4.40M	0.74%	4.40M
Ubs group	2.65M	0.00%	2.65M
Great point partners	1.15M	1.90%	1.15M
Ubs asset management americas	964.90K	0.00%	964.90K

Top Sellers

Holder	Shares	% Assets	Change
Millennium management	3.97M	0.01%	-1.43M
Morgan stanley	207.74K	0.00%	-1.17M
Adage capital partners gp	8.72M	0.05%	-1.00M
Price t rowe associates inc /md/	-	-	-991.97K
Tejara capital	2.32M	5.31%	-512.90K

New Positions

Holder	Shares	% Assets	Change	Value
Frazier life sciences management	4.40M	0.74%	4.40M	$15.84M
Ubs group	2.65M	0.00%	2.65M	$9.27M
Great point partners	1.15M	1.90%	1.15M	$4.03M
Ubs asset management americas	964.90K	0.00%	964.90K	$3.38M
Woodline partners lp	618.78K	0.01%	618.78K	$2.17M

Sold Out

Holder	Change
Plante moran financial advisors	-48.00
Quadrant capital group	-398.00
Tower research capital llc (trc)	-645.00
Ica group wealth management	-1.00K
Point72 asset management	-1.90K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	93	14.81%	108,788,635	2.89%	14	0.30%	38	18.75%	26	23.81%
Sep 30, 2024	81	-	105,735,860	5.18%	68	33.31%	32	-8.57%	21	-22.22%
Jun 30, 2024	80	-4.76%	100,517,090	19.63%	14	8870446.46%	34	-33.33%	27	125.00%
Mar 31, 2024	84	25.37%	84,026,001	6.98%	-	0.00%	51	34.21%	12	9.09%
Dec 31, 2023	67	17.54%	78,543,746	11.37%	65	1.91%	38	100.00%	11	-35.29%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
UBS (Lux) EF Biotech (USD) P-acc	855.00K	0.55%	336.80K
HealthInvest Sustainable Healthcare E	270.00K	0.17%	-
Tema Obesity & Cardiometabolic ETF	267.46K	0.17%	-
Tema Oncology ETF	261.68K	0.17%	-
iShares Genomics Immnlgy & Hlthcr ETF	246.60K	0.16%	-
abrdn Life Sciences Investors	160.38K	0.10%	160.38K
UBS Global Equity Biotech	128.03K	0.08%	128.03K
HealthInvest Alpha Fund C	120.00K	0.08%	120.00K
Alger LIfe Sciences Innovation Composite	102.58K	0.07%	-84.07K
Fidelity Nasdaq Composite Index	92.16K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 13, 2024	Scots-Knight Denise	Chief Executive Officer	Sell	$253.45K
Sep 12, 2024	Scots-Knight Denise	Chief Executive Officer	Sell	$127.97K
Sep 12, 2024	Lewicki John A.	Chief Scientific Officer	Sell	$23.31K
Sep 13, 2024	Lewicki John A.	Chief Scientific Officer	Sell	$46.17K
Sep 12, 2024	Sermon Charles	General Counsel	Sell	$44.64K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	-
2024 Q3	-	13
2024 Q2	-	12
2024 Q1	-	-

MREO Ownership FAQ

Who Owns Mereo BioPharma Group?

Mereo BioPharma Group shareholders are primarily institutional investors at 14.13%, followed by 1.03% insiders and 84.84% retail investors. The average institutional ownership in Mereo BioPharma Group's industry, Biotech Stocks , is 69.06%, which Mereo BioPharma Group falls below.

Who owns the most shares of Mereo BioPharma Group?

Mereo BioPharma Group’s largest shareholders are Janus henderson group (17.12M shares, 2.22%), Rubric capital management lp (15.31M shares, 1.99%), and Rock springs capital management lp (9.6M shares, 1.25%). Together, they hold 5.46% of Mereo BioPharma Group’s total shares outstanding.

Does Blackrock own Mereo BioPharma Group?

BlackRock is not among the top 10 institutional shareholders of Mereo BioPharma Group.

Who is Mereo BioPharma Group’s biggest shareholder by percentage of total assets invested?

Tejara capital is Mereo BioPharma Group’s biggest shareholder by percentage of total assets invested, with 5.31% of its assets in 2.32M Mereo BioPharma Group shares, valued at 8.11M$.

Who is the top mutual fund holder of Mereo BioPharma Group shares?

UBS (Lux) EF Biotech (USD) P-acc is the top mutual fund holder of Mereo BioPharma Group shares, with 0.55% of its total shares outstanding invested in 855K Mereo BioPharma Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools